Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alimemazine 10mg tablets
0304010Y0AAADAD
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 3,494 |
|
Alimemazine 7.5mg/5ml oral solution
0304010Y0AAABAB
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 2,132 |
|
Alimemazine 30mg/5ml oral solution
0304010Y0AAACAC
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 1,204 |
|
Alimemazine 7.5mg/5ml oral solution sugar free
0304010Y0AABCBC
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 455 |
|
Alimemazine 10mg/5ml oral solution sugar free
0304010Y0AABDBD
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 251 |
|
Alimemazine 30mg/5ml oral solution sugar free
0304010Y0AABBBB
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 224 |
|
Alimemazine 1.5mg/5ml oral solution
0304010Y0AABABA
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 10mg/5ml oral solution
0304010Y0AAAYAY
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 15mg/5ml oral solution
0304010Y0AAAUAU
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 5mg/5ml oral solution
0304010Y0AAAVAV
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 5mg/5ml oral suspension
0304010Y0AAAZAZ
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.